Request Speaker Information
Event Host
690 Canton Street
With unparalleled lowest Total Cost of Occupancy, 690 Canton is Suburban Boston’s Premier Adaptive Re-Use Life Science Conversion. Providing Move-In Ready R&D suites ranging from 5,000 RSF to 165,000 RSF, 690 Canton is the most versatile speculative project Southwest of Cambridge for graduate-level research companies through established HQ seeking organizations. Fastest Time to Occupancy, Lowest Cost of Occupancy, Experienced Ownership and a Highly Amenitized Work Live Play Shop location anchored by the Route 128 MBTA Commuter Rail/Amtrak Station. Another Route 128 project by Outshine Properties: Labs. Delivered™.
Our Commitment to Your Safety
We hosted more than 72,000 attendees live, in-person around the globe in 2021. Our commitment to safety is no different in 2022. Our events follow all local Covid-19 regulations and protocols.
At this event, this means you can expect:
Masks are required and will be available at the door.
Enhanced sanitization protocols will be adhered to throughout the event space including regularly disinfecting surfaces throughout the event and hand sanitizer provided to all attendees.
As venue and local regulations evolve, the CRE industry continues to lead the way forward. As such, we will gather safely to do what we do best: network, connect, and engage to do more business. We look forward to hosting you soon.
Speakers and Panels
Andrew Kimball
President & CEO
New York City Economic Development Corporation
Site Selection Strategies: Highest & Best Use of Life Science Campuses
Strategies Behind Campus vs. Stand Alone Facilities
Kate Bicknell
Managing Director
Tishman Speyer
Matthew Hawryluk
EVP, Chief Business Officer
Gritstone Bio
Kerry Hawkins
VP, Senior Director Asset Management
Hobbs Brook
Gary Kerr
Senior Managing Director
Greystar
Jason Seaburg
Life Sciences COO
Suffolk
Joe Mamayek
Principal
SGA
Thomas Joyner
Partner
AHA Consulting Engineers
Finding More Space: Navigating Repositioning
Targeting Conversions & Vacant Buildings
Young Park
CEO
Berkeley Garbe
Sandhya Iyer
Director, Economic Development
Town of Lexington
Raj Vora
National Life Sciences Core Market
DPR Construction
Paul Bauer
Partner
Bowditch & Dewey
Rob Zirkle
Founder & CEO
brick.
Navigating The Risk of GMP Facilities
Managing the up-front costs & Planning for Tenant Changes
Robert Albro
Partner, Chief Investment Officer
King Street Properties
Bill Hunter
Managing Director
Perceptive Real Estate Equities, Inc.
Lauren Laidlaw
Vice President, Sales and Marketing
Safety Partners
Christopher Stoddard
Associate Principal
Ennead Architects
Steve Lacerte
Principal, Project Management
Avison Young
Is Boston Ready for the City's Development Pipeline?
Assessing Deal Flow & Feasibility of More Life Science Development
Kenn Turner
President, CEO
Massachusetts Life Sciences Center
Joe Boncore
CEO
MassBio
Jeff Black
National Debt & Equity Platform Leader
Colliers- Boston
Joe Curtatone
President
Northeast Clean Energy Council
Ginger Desmond
Principal, Science and Technology
Stantec
Joseph Hanley
Partner
McDermott Quilty & Miller
Case Study on ISQ2: Enhancing Urban Manufacturing
How to Execute Lab Development in Boston's Seaport
Stephen Faber
EVP
Related Beal
Charles Pappalardo
VP, Global Operations and Real Estate
Vertex Pharmaceuticals
Jeannie Thacker
Principal
TRIA
Cory Pinheiro
Sr. Project Manager
Consigli Construction
Pat Duffy
President
BR+A
Why This Matters
What You'll Learn:
Boston's life science construction pipeline continues to hit new record highs. Will there be enough demand to match the supply and if so what does that mean for the future of Boston's economic development?
How are investors and developers making deals in an increasingly competitive life sciences market?
What is the projected long term value of investing in Boston's life science market? At what point is there a heightened risk associated with some of these life science assets?
How are GMP facilities, and what we know about them in Boston, evolving?
How are owners, developers and life science companies finding more space and what role is repositioning playing to create viable development locations?
How you'll do more business:
Enhance your business by gaining a stronger understanding of how the leading life science players are receiving strong return on their investments and where developers are finding more desirable development locations. Gain exclusive insight into how life science campuses are being executed, navigating GMP facility risk and understanding the evolution of the city's leading life science developments.
Who attends:
Investors, owners, developers, life science companies, end users, brokers, lawyers, designers, contractors, architects, property managers and advisors.
Why should you attend:
Bisnow events bring together the biggest power players in the industry to identify opportunities, build your network, and expand your business. With the largest audience of commercial real estate professionals in the world, no one knows how to help your business more than us.
Sign up for group tickets here.
For questions, recommendations, comments, or press inquiries please email our Boston Event Producer, Chris Picher at chris.picher@bisnow.com.
Venue
690 Canton Street
1st Floor – 690 Canton Street
Westwood, MA 02090
Parking information: Free parking on-premise
Agenda
| Time | Activity |
|---|---|
|
12:00 PM
1:00 PM
|
Breakfast, Coffee & Networking
|
|
1:00 PM
1:40 PM
|
Site Selection Strategies: Highest & Best Use of Life Science Campuses
1. How are developers analyzing site selection, especially with increasing prices and competition? |
|
1:40 PM
2:20 PM
|
Is Boston Ready for the City's Development Pipeline?
1. How is the city managing the increased life sciences construction pipeline? |
|
2:20 PM
2:35 PM
|
Networking & Coffee
|
|
2:35 PM
3:15 PM
|
Case Study on ISQ2: Enhancing Urban Manufacturing
1. Deep dive look into Boston Seaport's ISQ2 development |
|
3:15 PM
3:55 PM
|
Finding More Space: Navigating Repositioning
1. How do developers assess which existing assets are primed for repositioning? |
|
3:55 PM
4:35 PM
|
Navigating the Risk of GMP Facilities
1. How are GMP facilities evolving with the speed at which life sciences companies are expanding? |
|
4:35 PM
4:45 PM
|
Light Lunch & Snacks
|